MRLOX | RLBAX | MRLOX / RLBAX | |
Total Expense Ratio | 1.46 | 1.33 | 110% |
Annual Report Gross Expense Ratio | 1.49 | 1.33 | 112% |
Fund Existence | 22 years | 23 years | - |
Gain YTD | 0.524 | -2.348 | -22% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100 | 250 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.8B | 235B | 7% |
Annual Yield % from dividends | 0.95 | 1.27 | 75% |
Returns for 1 year | -2.29 | 0.57 | -403% |
Returns for 3 years | -3.99 | 7.24 | -55% |
Returns for 5 years | 13.66 | 41.60 | 33% |
Returns for 10 years | -7.96 | 41.83 | -19% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
UTRE | 49.69 | 0.30 | +0.60% |
US Treasury 3 Year Note ETF | |||
IBDS | 24.18 | 0.08 | +0.33% |
iShares iBonds Dec 2027 Term Corp ETF | |||
DHF | 2.51 | -0.03 | -1.18% |
BNY Mellon High Yield Strategies Fund | |||
XJUL | 34.59 | -0.93 | -2.62% |
FT Vest U.S. Eq Enh & ModBufETF-Jul | |||
LABU | 53.61 | -5.82 | -9.79% |
Direxion Daily S&P Biotech Bull 3X ETF |